Literature DB >> 3027448

Biochemical phenotyping of a single sibship with both cystinosis and Fabry disease.

W A Gahl, M Adamson, I Kaiser-Kupfer, I H Ludwig, H J O'Connell, W Cohen, J Barranger.   

Abstract

Two lysosomal storage diseases, cystinosis and Fabry disease, were diagnosed clinically in different members of a single sibship. The possibility that the affected sister and brother might have related disorders with disparate manifestations was pursued. The four principal family members were tested for heterozygote status with respect to serum and leukocyte alpha-galactosidase A activity, urinary trihexosylceramide excretion, and the capacity to engage in cystine counter-transport across leukocyte lysosome membranes. Results were consistent with classical autosomal recessive inheritance in the case of cystinosis and X-linked inheritance for Fabry disease, confirming that this family represents an example of two rare disorders occurring in the same sibship.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3027448     DOI: 10.1007/BF01819297

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Fabry disease: diagnosis by alpha-galactosidase activities in tears.

Authors:  D L Johnson; M A Del Monte; E Cotlier; R J Desnick
Journal:  Clin Chim Acta       Date:  1975-08-18       Impact factor: 3.786

2.  [Cornea verticillata].

Authors:  J François
Journal:  Bull Soc Belge Ophtalmol       Date:  1968

3.  Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes.

Authors:  W A Gahl; F Tietze; N Bashan; R Steinherz; J D Schulman
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

4.  Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts.

Authors:  A Hasilik; A Waheed; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

5.  Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples.

Authors:  R G Oshima; R C Willis; C E Furlong; J A Schneider
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

6.  Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts.

Authors:  P Strisciuglio; K E Creek; W S Sly
Journal:  Pediatr Res       Date:  1984-02       Impact factor: 3.756

7.  The relation between human lysosomal beta-galactosidase and its protective protein.

Authors:  A T Hoogeveen; F W Verheijen; H Galjaard
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Fabry disease: detection of heterozygotes by examination of glycolipids in urinary sediment.

Authors:  W J Cable; R H McCluer; E H Kolodny; M D Ullman
Journal:  Neurology       Date:  1982-10       Impact factor: 9.910

9.  Elevated cystine levels in cultured skin fibroblasts from patients with I-cell disease.

Authors:  F Tietze; J D Butler
Journal:  Pediatr Res       Date:  1979-12       Impact factor: 3.756

10.  Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.

Authors:  M L Reitman; A Varki; S Kornfeld
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  2 in total

1.  Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.

Authors:  H S Bernstein; D F Bishop; K H Astrin; R Kornreich; C M Eng; H Sakuraba; R J Desnick
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 2.  Fabry disease in infancy and early childhood: a systematic literature review.

Authors:  Dawn A Laney; Dawn S Peck; Andrea M Atherton; Linda P Manwaring; Katherine M Christensen; Suma P Shankar; Dorothy K Grange; William R Wilcox; Robert J Hopkin
Journal:  Genet Med       Date:  2014-09-18       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.